USPTO serial 90038729
INSPIRED TO CURE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FOSDICK, GEOFFREY A
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with INSPIRED TO CURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brendan J. Hughes
Brendan J. Hughes COOLEY LLP1299 Pennsylvania Avenue, NW, Suite 700Washington, DC 20004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Cell therapy pharmaceutical preparations; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders | ACTIVE | — |
| 035 | Promoting public awareness of issues related to the testing, diagnosis, treatment and patient outcome in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders; promoting the interests of patients with cancer, and blood and bone marrow diseases and disorders, by means of public advocacy | ACTIVE | — |
| 036 | Providing information regarding insurance coverage and reimbursement for prescription drugs; administration of a patient assistance program for providing prescription drugs at reduced cost | ACTIVE | — |
| 042 | Research and development in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders; providing medical and scientific research information in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders | ACTIVE | — |
| 044 | Providing educational medical information in the fields of in the fields of pharmaceuticals, cell therapies, hematology, leukemia, oncology, and blood and bone marrow diseases and disorders, including the testing, diagnosis, treatment and patient outcomes related thereto; Medical services, namely, providing educational information regarding prescription drugs and disease treatment; providing a call center for responding to patient and caregiver inquiries and providing educational guidance in the field of prescription pharmaceuticals and disease treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Gamida Cell Inc.
- Other trademarks owned by Gamida Cell Inc.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named INSPIRED TO CURE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 15, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 15, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 15, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 15, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 15, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 14, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 14, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 13, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 9, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 9, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 9, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 12, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 17, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 17, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 28, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 15, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 15, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 10, 2020 | NWAP | NEW APPLICATION ENTERED | — |